Document is current

Any future updates will be listed below

Assessment of Drug–Drug Interaction Risk Between Intravenous Fentanyl and the Glecaprevir/Pibrentasvir Combination Regimen in Hepatitis C Patients Using Physiologically Based Pharmacokinetic Modeling and Simulations

Crossref DOI link: https://doi.org/10.1007/s40121-023-00830-0

Published Online: 2023-07-20

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark